ABVC Biopharma Files Amendment on Delisting Concerns
Ticker: ABVC · Form: 8-K/A · Filed: May 14, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K/A |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: delisting, amendment, compliance
TL;DR
ABVC Bio is amending its delisting notices, trying to stay listed after past issues.
AI Summary
ABVC Biopharma, Inc. filed an amendment (8-K/A) on May 14, 2025, to its previous filings concerning the delisting of its securities. The amendment addresses events that occurred on July 12, 2024, and January 13, 2025, related to the company's continued listing standards.
Why It Matters
This filing is important as it provides updated information regarding ABVC Biopharma's compliance with stock exchange listing rules, which can significantly impact investor confidence and stock liquidity.
Risk Assessment
Risk Level: medium — The filing relates to delisting concerns, indicating potential financial or operational challenges that could affect the company's stock.
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- July 12, 2024 (date) — Event date
- January 13, 2025 (date) — Event date
- May 14, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose is to amend previous filings related to the notice of delisting or failure to satisfy continued listing rules or standards.
What are the key dates associated with the events reported in this amendment?
The earliest event reported occurred on July 12, 2024, with subsequent events on January 13, 2025.
What is the filing date of this amendment?
This amendment was filed as of May 14, 2025.
What is the company's state of incorporation?
The company is incorporated in Nevada.
What is the company's SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 14, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).